The chief financial officer of Omnicell plans to step down sometime this year. The maker of automated medication-management systems said Wednesday that Nchacha Etta intends to depart on Sept.

FORT WORTH, Texas, March 12, 2025--(BUSINESS WIRE)--Omnicell, Inc. (NASDAQ:OMCL) ("Omnicell," "we," "our," "us," "management," or the "Company"), a leader in ...

For anyone who wants to understand Omnicell's profit beyond the statutory numbers, it's important to note that during the last twelve months statutory profit was reduced by US$5.2m due to unusual ...

Omnicell, Inc. OMCL has witnessed strong momentum in the past year. Shares of the company have risen 41.6% against a 11.3% decline of the industry during the same time frame. The S&P 500 composite ...

Omnicell (OMCL) announced that Nchacha Etta will be stepping down from his role as executive VP and CFO, effective September 15 or until a successor is named. Etta will continue to serve as CFO ...

Omnicell stock opened at $36.99 on Thursday. The stock has a market cap of $1.73 billion, a P/E ratio of 137.01, a price-to-earnings-growth ratio of 7.53 and a beta of 0.85. The company has a ...

Omnicell, Inc. (NASDAQ:OMCL) (“Omnicell,” “we,” “our,” “us,” “management,” or the “Company”), a leader in transforming the pharmacy and ...